Table 1.
Sera ID | 1st DOSE | 2nd DOSE | Vaccine Status | SEX | AGE |
---|---|---|---|---|---|
SP001 | Late Dec/2020 | Mid Jan/2021 | (+) | M | 45–50 |
SP002 | Late Dec/2020 | Mid Jan/2021 | (+) | M | 40–45 |
SP003 | Late Dec/2020 | Mid Jan/2021 | (+) | M | 55–60 |
SP004 | Late Dec/2020 | Mid Jan/2021 | (+) | M | 50–55 |
SP005 | Late Dec/2020 | Mid Jan/2021 | (+) | M | 35–40 |
SP006 | Late Dec/2020 | Mid Jan/2021 | (+) | F | 35–40 |
SP007 | Late Dec/2020 | Mid Jan/2021 | (+) | F | 20–25 |
SP008 | Late Dec/2020 | Early Feb/2021 | (+) | M | 35–40 |
SP009 | Late Dec/2020 | Early Feb/2021 | (+) | F | 30–35 |
SP010 | Late Dec/2020 | Mid Jan/2021 | (+) | M | 30–35 |
SP011 | Late Dec/2020 | Mid Jan/2021 | (+) | M | 40–45 |
SP012 | Late Dec/2020 | Mid Jan/2021 | (+) | M | 25–30 |
Median Age | 39.5 | ||||
Range | 25–56 | ||||
SP013 | N.A. | N.A. | (−) | F | 45–50 |
SP014 | N.A. | N.A. | (−) | F | 50–55 |
SP015 | N.A. | N.A. | (−) | M | 40–45 |
N.A., Not Applicable